A Mouse Model for Human Osteogenesis Imperfecta Type VI

被引:44
|
作者
Bogan, Rosalind [1 ]
Riddle, Ryan C. [1 ,2 ]
Li, Zhu [1 ]
Kumar, Sarvesh [1 ]
Nandal, Anjali [1 ]
Faugere, Marie-Claude [3 ]
Boskey, Adele [4 ]
Crawford, Susan E. [5 ]
Clemens, Thomas L. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21287 USA
[2] Baltimore Vet Adm Med Ctr, Baltimore, MD USA
[3] Univ Kentucky, Dept Med, Lexington, KY 40506 USA
[4] Hosp Special Surg, Mineralized Tissue Res Lab, New York, NY 10021 USA
[5] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA
关键词
PEDF; OSTEOGENESIS IMPERFECTA; BONE MINERALIZATION; OSTEOBLAST; EPITHELIUM-DERIVED FACTOR; BONE HISTOMORPHOMETRY; PEDF; MUTATIONS; RECEPTOR; NOMENCLATURE; DEFICIENCY; SERPINF1; COLLAGEN; SYMBOLS;
D O I
10.1002/jbmr.1892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteogenesis imperfecta type VI (OI type VI) has recently be linked to a mutation in the SERPINF1 gene, which encodes pigment epithelium-derived factor (PEDF), a ubiquitously expressed protein originally described for its neurotrophic and antiangiogenic properties. In this study, we characterized the skeletal phenotype of a mouse with targeted disruption of Pedf. In normal mouse bone, Pedf was localized to osteoblasts and osteocytes. Micro-computed tomography (mu CT) and quantitative bone histomorphometry in femurs of mature Pedf null mutants revealed reduced trabecular bone volume and the accumulation of unmineralized bone matrix. Fourier transform infrared microscopy (FTIR) indicated an increased mineral:matrix ratio in mutant bones, which were more brittle than controls. In vitro, osteoblasts from Pedf null mice exhibited enhanced mineral deposition as assessed by Alizarin Red staining and an increased mineral:matrix determined by FTIR analysis of calcified nodules. The findings in this mouse model mimic the principal structural and biochemical features of bone observed in humans with OI type VI and consequently provide a useful model with which to further investigate the role of PEDF in this bone disorder.
引用
收藏
页码:1531 / 1536
页数:6
相关论文
共 50 条
  • [1] Generation and Characterization of a Conditional Mouse Model for Atypical Type VI Osteogenesis Imperfecta
    Robinson, Samantha
    Rauch, Frank
    Moffatt, Pierre
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 350 - 350
  • [2] Bone matrix mineralization in osteogenesis imperfecta type VI
    Fratzl-Zelman, N.
    Roschger, P.
    Schmidt, I.
    Glorieux, F.
    Klaushofer, K.
    Fratzl, P.
    Wagermaier, W.
    Rauch, F.
    BONE, 2012, 51 (06) : S14 - S14
  • [3] Craniofacial Effects of Zoledronic Acid on the Osteogenesis Imperfecta Mouse (-/-) Model of Severe Osteogenesis Imperfecta
    Jeannerod, Gaspard
    Chretien, Antoine
    Andre, Gregoire
    Mabilleau, Guillaume
    Behets, Catherine
    BIOMEDICINES, 2024, 12 (12)
  • [4] Metabolic phenotype in the mouse model of osteogenesis imperfecta
    Boraschi-Diaz, Iris
    Tauer, Josephine T.
    El-Rifai, Omar
    Guillemette, Delphine
    Lefebvre, Genevieve
    Rauch, Frank
    Ferron, Mathieu
    Komarova, Svetlana V.
    JOURNAL OF ENDOCRINOLOGY, 2017, 234 (03) : 279 - 289
  • [5] Fecundity is impaired in a mouse model of osteogenesis imperfecta
    Oestreich, Arin K.
    DeCata, Jenna A.
    Akers, Janae D.
    Phillips, Charlotte L.
    Schulz, Laura. C.
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2020, 87 (09) : 927 - 929
  • [6] Osteogenesis Imperfecta Type VI in Individuals from Northern Canada
    Leanne Ward
    Ghalib Bardai
    Pierre Moffatt
    Hadil Al-Jallad
    Pamela Trejo
    Francis H Glorieux
    Frank Rauch
    Calcified Tissue International, 2016, 98 : 566 - 572
  • [7] Osteogenesis Imperfecta Type VI in Individuals from Northern Canada
    Ward, Leanne
    Bardai, Ghalib
    Moffatt, Pierre
    Al-Jallad, Hadil
    Trejo, Pamela
    Glorieux, Francis H.
    Rauch, Frank
    CALCIFIED TISSUE INTERNATIONAL, 2016, 98 (06) : 566 - 572
  • [8] A co-occurrence of osteogenesis imperfecta type VI and cystinosis
    Tucker, Tracy
    Nelson, Tanya
    Sirrs, Sandra
    Roughley, Peter
    Glorieux, Francis H.
    Moffatt, Pierre
    Schlade-Bartusiak, Kamilla
    Brown, Lindsay
    Rauch, Frank
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (06) : 1422 - 1426
  • [9] Anti-sclerostin antibodies and Intermittent PTH increase bone mass and strength in a mouse model of Type VI Osteogenesis Imperfecta
    Gerbaix, Maude
    Thouverey, Cyril
    Badoub, Isabelle
    Viallon, Solene
    Roche, Bernard
    Tomlinson, Ryan
    Crawford, Susan
    Helene, Lafage Proust Marie
    Serge, Ferrari
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 96 - 96
  • [10] Genetic Inactivation of Sclerostin in a Mouse Model of Osteogenesis Imperfecta
    Boraschi-Diaz, Iris
    Tauer, Josephine T.
    Rauch, Frank
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 366 - 366